Cure My Disease

Don't miss your cure!

 Log in / Sign up

Text messages as medicine: digital program aims to improve life with PCOS

NCT ID NCT07684430

Disease control Sponsor: Near East University, Turkey Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether a four-week digital health education program delivered via WhatsApp can improve quality of life in women with polycystic ovary syndrome (PCOS). Seventy women aged 18–45 with PCOS are randomly assigned to receive either the digital program—30 structured messages covering lifestyle, nutrition, stress, and fertility—or routine care. Quality of life is measured before and one month after the program using a PCOS-specific questionnaire.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Digital health education program (WhatsApp-based)
What this could lead to
If effective, this low-cost digital program could offer a scalable way to help women with PCOS manage symptoms and improve daily well-being.
What could go wrong
This is a small, single-site trial with 70 participants, so results may not apply broadly. The program is educational only and does not treat the underlying condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

70 people

The number who actually took part.

Started

Apr 2026

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Women diagnosed with polycystic ovary syndrome 2. Women aged 18-45 years 3. Women attending the selected women's health wards and gynecology clinics during the study period 4. Willingness to participate and provide written informed consent Exclusion Criteria: 1. Withdrawal of consent at any stage of the study 2. Failure to complete either the pre-test or post-test assessments 3. Incomplete participation in the educational intervention program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Polycystic ovary syndrome (PCOS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Health Education polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Polycystic ovary syndrome (PCOS)

Contacts and locations

Locations

  • Pouran Varvani Farahani

    Nicosia, Haspolat, Cyprus

More trials for these conditions

Other studies related to the condition(s) this trial covers.